(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid, 95.0%, 250mg

5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline, 95.0%, 250mg

4-Phenyl-[1,2,3]thiadiazole-5-carboxylic acid ethyl ester, 95.0%, 10g

N-(2',6'-DINETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE HCL, 95.0%, 5g

N-(tert-Butoxycarbonyl)-O-tert-butyl-L-tyrosine>98.0%(HPLC)(T)5g

2-methyl-6-(thiophen-3-yl)pyrimidin-4-ol, 95.0%, 250mg

2-[1-(Ethanesulfonyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]azetidin-3-yl]acetonitrile, 97%, 5g

Isobutyl methyl ketone, 99.5% min, VLSI Grade, 2.5L, plastic bag.

methyl 2-methyl-3-[(pentan-3-yl)amino]propanoate, 95.0%, 10g

2-hydroxy-7-methylquinoline-3-carbaldehyde, 95.0%, 250mg

Bismuth foil 99.99% 0.25 x 25 x 25 mm 1 pc

5-Bromo-2-(piperazin-1-yl)thiazole, 95+%, 5g

2,4-Bis(4-methylpiperazin-1-yl)aniline, 97%, 250mg